21/17157 - Enhanced quadrivalent vaccine against seasonal influenza for the 2022/2023 flu season

The Norwegian Institute of Public Health (NIPH) is carrying out procurement of an enhanced quadrivalent vaccine against seasonal influenza for vaccination of people aged 65 or older in nursing homes. Enhanced influenza vaccine is a vaccine that is more effective than the ordinary influenza vaccine that is offered to other target groups included in the national immunisation scheme. The procurement is governed by the provisions in parts I and III of the Norwegian Regulations relating to public procurement (Forskrift om offentlige anskaffelser, FOA). The procurement is held as an open tender contest and will be carried out using the electronic competition administration tool (KGV), CTM (EU-Supply).

Supplies

31/01/2022 13:00:00

33651660-2  Influenza vaccines
33651600-4  Vaccines


Folkehelseinstituttet
Lovisenberggata 8
0456
OSLO
Norway
View profile

Ole Andreas Fuglesang
http://www.fhi.no

Published notices
02.Contract notice (Doffin (v209)) 21/12/2021 10:44
03. Contract award notice (Doffin (v209)) 25/04/2022 09:20
Packages
Enhanced quadrivalent vaccine against seasonal influenza for the 2022/2023 flu season
Additional information:
Documents Documents
Close